Love this... Supplying the Global Demand
With the influence of COVID-19 spanning the globe, the need for ScreenPro Security to provide its services outside of North America becomes increasingly apparent. Just recently announced, London Mayor Sadiq Khan suggested an increase to community testing through the creation of roughly 85 new test centers, 45 of which are to be mobile. Sparking the need for additional support, companies such as ScreenPro’s partner, Enoura Medical are in discussions with the NHS on supplying test kits and ancillary products, whom conveniently have registered ScreenPro Security products for use in the UK. Complimented by a 900 million RFP and armed with approval as a vendor for the NHS, Enoura is well supported to assist for the surge in required testing in the UK, and ScreenPro can drastically benefit from the potential partnership with Enoura. ScreenPro Security and Enoura Medical are also in talks with potential government health officials overseas and speaking to them about facilitating a complete solution for testing their populations as the need for reliable test kits around the world heighten. The majority of the products offered by ScreenPro Security are FDA approved, Health Canada, as well as CE approved, allowing the company to extend its offerings into the UK, Europe, Africa, USA, and Canada. Although the supply and distribution of pharmaceutical supplies is a massive business in America, they are experiencing shortages on many of the products required to support a healthy society. The company’s ability to stay on-top of demand and never falter from delivery dates, making an extensive profit albeit, is growing the company’s reputation as the industry leader for reliable rapid testing.
The issue moving forward will be finding the required space and manpower to satisfy the needs of the masses. ScreenPro has cultivated a unique approach, utilizing brand new facilities left empty by the fallout of the cannabis industry and electing to support the conversion of these facilities into licensed operations. The government has reached out to several of these labs, however most shy away due to the extensive work required to get started. ScreenPro Security viewed this as an opportunity, and by connecting with specific lab teams willing to participate and offering to get the lab running, beneficially inputting its very own testing equipment, such as PCR machines, rapid extraction tables and UTM’s, within a matter of days these labs can apply for their licensing and become fully functional. This magnitude of support will provide large markets that are hot spots and in high demand of assistance the supply and analysis of reliable COVID-19 testing deemed necessary by governments everywhere. One can conclude that ScreenPro has the ability to offer unparallel service through its innovative technologies, backed by a robust supply chain with unmatched availability. As the product becomes increasingly relevant and required to support the global pandemic, one can surely assume that revenues will begin to multiply, carrying its market cap along for the ride for investors to enjoy.